Ergoteles’s Atreca, Inc. Class A Common Stock BCEL Stock Holding History

Ergoteles’s Portfolio BCEL Stock Details BCEL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-107,783	Closed	-$169K	–	2017
2022 Q3	$169K	Sell	107,783 -6,317	-6%	-$13K	0.01%	1241
2022 Q2	$204K	Buy	+114,100	New	+$238K	0.01%	1317
2021 Q3	–	Sell	-21,500	Closed	-$183K	–	1790
2021 Q2	$183K	Buy	+21,500	New	+$220K	﹤0.01%	1308

Other funds holding BCEL

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Gates Foundation Seattle, Washington $43.5M AUM 14.19% 1-Year Est. Return

LCM

Laurion Capital Management New York $3.9B AUM 75.03% 1-Year Est. Return

Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return

Samsara BioCapital Palo Alto, California $1.22B AUM 242.83% 1-Year Est. Return

ACM

Aisling Capital Management New York $472M AUM 106.83% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $2.05B AUM 161.37% 1-Year Est. Return

Ergoteles's BCEL Position: Q4 2022 in Review

Ergoteles sold out of Atreca, Inc. Class A Common Stock (BCEL) in Q4 2022, closing a stake of 107,783 shares — an estimated $169K sold.

Ergoteles first reported a position in BCEL in Q2 2021 and held it in 3 quarters. The position peaked at $204K in Q2 2022. 58 funds tracked by Wall St. Rank hold BCEL as of Q4 2022.

Ergoteles reported no remaining Atreca, Inc. Class A Common Stock position as of Q4 2022 after selling out during the quarter.
Ergoteles sold 107,783 Atreca, Inc. Class A Common Stock shares in Q4 2022, an estimated $169K.
Ergoteles first reported a position in Atreca, Inc. Class A Common Stock in Q2 2021 and held it in 3 quarters.
Ergoteles's Atreca, Inc. Class A Common Stock position peaked at $204K in Q2 2022.
58 funds tracked by Wall St. Rank held Atreca, Inc. Class A Common Stock as of Q4 2022.

Based on Ergoteles's 13F filing for Q4 2022, filed 14 Feb 2023.